PTC Therapeutics Inc (PTCT)

68.49 -0.23  -0.33% NASDAQ Jan 15, 20:00 USD
View Full Chart
Price Chart
View All PTCT News

News

View All Events

Events

Date Type Description
03/02/2021 Earnings PTC Therapeutics Inc Fourth Quarter Earnings for 2020 Release
03/02/2021 16:30 EST Misc PTC Therapeutics Inc Fourth Quarter Earnings Conference Call for 2020
10/29/2020 16:30 EDT Misc PTC Therapeutics Inc Third Quarter Earnings Conference Call for 2020
10/29/2020 Earnings PTC Therapeutics Inc Third Quarter Earnings Result for 2020
08/05/2020 16:30 EDT Misc PTC Therapeutics Inc Second Quarter Earnings Conference Call for 2020
08/05/2020 Earnings PTC Therapeutics Inc Second Quarter Earnings Result for 2020
06/10/2020 09:00 EDT Misc PTC Therapeutics Inc Annual General Meeting for 2019
04/30/2020 16:30 EDT Misc PTC Therapeutics Inc First Quarter Earnings Conference Call for 2020
04/30/2020 Earnings PTC Therapeutics Inc First Quarter Earnings Result for 2020
03/02/2020 16:30 EST Misc PTC Therapeutics Inc Fourth Quarter Earnings Conference Call for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.ptcbio.com
  • Investor Relations URL: http://ir.ptcbio.com/
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Mar. 02, 2021
  • Last Earnings Release: Oct. 29, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.

Top Fund Holders

Symbol Name Weighting
FRBRX Franklin Biotechnology Discovery R6 3.20%
FIJYX Fidelity Advisor® Biotechnology Z 1.82%
FBIOX Fidelity® Select Biotechnology 1.73%
HFMRX Hartford MidCap R3 1.49%
HBMCX Hartford MidCap HLS IB 1.46%
FSSRX Franklin Small Cap Growth R 1.32%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.